Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-25
2006-04-25
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07034054
ABSTRACT:
The present invention provides method for the treatment of a symptom of neuronal damage associated with cerebral ischemia comprising administering gamma-, beta-, or delta-tocopherol enriched tocopherol compositions.
REFERENCES:
patent: 3755560 (1973-08-01), Dickert et al
patent: 4150038 (1979-04-01), Wingard
patent: 4254105 (1981-03-01), Fukuda
patent: 4421769 (1983-12-01), Dixon et al.
patent: 4894449 (1990-01-01), Venero et al.
patent: 4960764 (1990-10-01), Figueroa, Jr. et al.
patent: 4977282 (1990-12-01), Baldwin et al.
patent: 4978617 (1990-12-01), Furuya
patent: 5114957 (1992-05-01), Hendler et al.
patent: 5139796 (1992-08-01), Barkalow et al.
patent: 5200214 (1993-04-01), Barkalow et al.
patent: 5235073 (1993-08-01), Kim et al.
patent: 5296469 (1994-03-01), Orjales-Venero et al.
patent: 5504220 (1996-04-01), Kuo et al.
patent: 5606080 (1997-02-01), Ogata et al.
patent: 5648331 (1997-07-01), Koudsi et al.
patent: 5733926 (1998-03-01), Gorbach
patent: 5756538 (1998-05-01), Cassels et al.
patent: 5801159 (1998-09-01), Miller et al.
patent: 5808140 (1998-09-01), Haridas
patent: 5840759 (1998-11-01), Mitchell et al.
patent: 5855892 (1999-01-01), Potter et al.
patent: 5872108 (1999-02-01), Sandage, Jr. et al.
patent: 5914112 (1999-06-01), Bednar et al.
patent: 5945432 (1999-08-01), Bednar et al.
patent: 5952374 (1999-09-01), Clarkson, Jr. et al.
patent: 6048891 (2000-04-01), Wechter
patent: 6063819 (2000-05-01), Marangos et al.
patent: 6068844 (2000-05-01), Becker et al.
patent: 6083982 (2000-07-01), Wechter et al.
patent: 6150402 (2000-11-01), Wechter et al.
patent: 6242479 (2001-06-01), Wechter
patent: 6297281 (2001-10-01), Chabrier de Lassauniere et al.
patent: 6346544 (2002-02-01), Hensley et al.
patent: 6410589 (2002-06-01), Wechter
patent: 6555575 (2003-04-01), Wechter
patent: 2002/0006954 (2002-01-01), Hensley et al.
patent: 2002/0165270 (2002-11-01), Remacle et al.
patent: 2004/0029954 (2004-02-01), Wechter
patent: 2004/0058986 (2004-03-01), Wechter
patent: 2004/0058987 (2004-03-01), Wechter
patent: 0 326 987 (1989-09-01), None
patent: 58018374 (1983-02-01), None
patent: 98/09653 (1998-03-01), None
patent: WO 00/35444 (2000-06-01), None
patent: WO 00/56348 (2000-09-01), None
Jiang et al., Proceedings of the National Academy of Sciences, 97/21, 11494-11499 (Oct. 10, 2000).
Alberts, B. et al. (1994).Molecular Biology of The Cell. Garland Publishing, Inc., Third Edition. New York . pg. xiii-xxxviii. (Table of Contents).
Altura, B. M. and Gebrewold, A. (1996). “α-Tocopherol Attenuates Alcohol-Induced Cerebral Vascular Damage in Rats: Possible Role of Oxidants in Alcohol Brain Pathology ad Stroke,”Neuroscience Letters220:207-210.
Anderson, J. J. B. and Garner, S. C. (Dec. 1998). “Phytoestrogens and Bone,”Bailliéres Clin. Endocrinol. Metab. 12(4):543-557.
Arora, A. et al. (1998). “Antioxidant Activities of Isoflavones and Their Biological Metobolites in a Liposomal System,”Arch. Biochem. Biophys. 356(2):133-141.
Arthur, H. R. et al. (1956). “An Examination of the Rutaceae of Hong Kong Part I. Flavonoid Glycosides fromZanthoxylumSpecies and the Occurrance of Optically Active Hesperetin,”J. Chem. Soc. 127:632-635.
Atkinson, D. E. (1977).Cellular Energy Metabolism and Its Regulation. Academic Press, Inc., New York. pp. vii-viii. (Table of Contents).
Benet, L. Z. et al. (Dec. 1995).Goodman and Gilman's The Pharmacological Basis of Therapeutics. Ninth Edition, J.G., eta l. eds., McGraw-Hill Health Professions Division. pp. v-xii (Table of Contents).
Bernier, M. et al. (1991). “Pharmacological Studies of Arrhythmias Induced by Rose Bengal Photoactivation,”Free Radical Biology&Medicine10:287-296.
Bjeldanes, L. F. and Chang, G. W. (Aug. 1977). “Mutagenic Activity of Quercetin and Related Compounds,”Science197:577-578.
Boersma, B. J. et al. (Aug. 1999). “Chlorination and Nitration of Soy Isoflavones,”Arch. of Biochem. and Biophys. 368(2):265-275.
Bonnefont-Rousselot, D. et al. (1999). “Antioxidant Effect of Probucol on RO2./O2.−-Induced Peroxidation of Human Low-Density Lipoproteins,”Radiat. Res. 151:343-353.
Bose, J. L. and Siddiqui, S. (1950). “A Note on the Constitution of Biochanin A,”J. Sci. Ind. Res. V. 9B:25-26.
Brent, J. A. et al. (1993). “Role of Free Radicals in Toxic Hepatic Injury II. Are Free Radicals The Cause of Toxin-Induced Liver Injury?”Clin. Toxicol. 31(1):173-196.
Brown, J. P. et al. (1978). “Flavonoid Sweeteners. Synthesis and Intestinal Absorption of Selected Sulfoalkylated Hesperetin-3-14C Derivative in the Rat,”J. Agric. Food Chem. 26(6):1418-1422.
Cassio, D. et al. (Dec. 1991). “Hybrid Cell Lines Constitute A Potential Reservoir of Polarized Cells: Isolation and Study of Highly Differentiated Hepatoma-Derived Hybrid Cells Able to Form Functional Bile Canaliculi In Vitro,”J. Cell Biol. 115(5):1397-1408.
Castro, L. et al. (Nov. 1994). “Aconitase Is Readily Inactivated by Peroxynitrite, but Not by Its Precursor, Nitric Oxide,”J. Biol. Chem. 269(47):29409-29415.
Chen, M-F. et al. (1999). “The Role of Vitamin E on the Anti-Atherosclerotic Effect of Fish Oil in Diet-Induced Hypercholesterolemic Rabbits,”Prostaglandins and Other Lipid Mediat. 57:99-111.
Choi, D.W. (Oct. 1988). “Glutamate Neurotoxicity and Diseases of the Nervous System,”Neuron1:623-634.
Ciolino, H. P. et al. (Jul. 1998). “Diosomin and Diosmetin Are Agonists of the Aryl Hydrocarbon Receptor That Differentially Affect Cytochrome P450 1A1 Activity,”Cancer Res. 58:2754-2760.
Coward, L. et al. (1993). “Genistein, Daidzein, and Their β-Glycoside Conjugates: Antitumor Isoflavones in Soybean Foods from American and Asian Diets,”J. Agri. Food Chem. 41:1961-1967.
Cuzzocrea, S. et al. (1998). “AntiInflammatory Effects of Mercaptoethylguanidine, A Combined Inhibitor of Nitric Oxide Synthase and Peroxynitrate Scavenger, in Carrageenan-Induced Models of Inflammation,”Free Radic. Biol. Med. 24(3):450-459.
Danesh, J. et al. (May 1998). “Association of Fibrinogen, C-Reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease: Meta-Analyses of Prospective Studies,”JAMA279(18):1477-1482.
DeGirolami, U. (Mar. 1982). “Neuropathology of Experimental Spinal Cord Ischemia in the Rabbit,”J. Neuropath. and Exp. Neurol. 41(2):129-149.
Diplock, A. T. et al. (1998). “Functional Food Science and Defence Against Reactive Oxidative Species,”Br. J. Nutr. 80(suppl. 1):S77-S112.
Dumon, M. F. et al. (1994). “Mise En Évidence De L' Effet Antilipoperoxydant Du 7 Rutinoside De La 3′,5,7-Trihydroxy-4′-Methoxy Flavone: Étude In Vitro,”Ann. Biol. Clin. 52:265-270.
Esaki, S. et al. (1994). “Preparation and Taste of Certain Glycosides of Flavanones and of Dihydrochalcones,”Biosci. Biotechnol. Biochem58(8):1479-1485.
Fernholz, E. (Jun. 1937). “The Thermal Decomposition of α-Tocopherol,”Communication to The Editor59:1154-1155.
Fernholz, E. (Jun. 1937). “On the Constitution of α-Tocopherol,”Communication to the Editor60:700-705.
Flynn, C. J. et al. (1989). “Ischemia and Hypoxia” Chapter 40 In:Basic Neurochemistry. G. J. Siegel et al. eds., Raven Press, New York pp. 783-810.
Freneix-Clerc, M. et al. (1994). “In Vivo Study of the Antilipoperoxidant Effect of 3′,5,7-Trihydroxy-4′-Methoxy Flavone 7 Rutinoside,”Ann. Biol. Clin. 52:171-177. (English Summary).
Fridovich, I. (Jul. 1997). “Superoxide Anion Radical (Oimg id="CUSTOM-CHARACTER-00001" he="3.13mm" wi="1.02mm" file="US07034054-20060425-P00701.TIF" alt="custom character" img-content="character" img-format="tif" ?), Superoxide Dismutases, and Related Matters,”J. of Biol. Chem. 272(30):18515-18517.
Fukuzawa, K. et al. (1982). “Antioxidant Activities of Tocopherols on Fe2+- Ascorbate-Induced Lipid Peroxidation in
Boddupalli Sekhar
Brown Lesley A.
Del Balzo Ughetta
Flaim Stephen
Miller Guy
Galileo Pharmaceuticals, Inc.
Spivack Phyllis G.
Stratford Carol A.
Walker Michelle Y.
LandOfFree
Methods for the prevention and treatment of cerebral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the prevention and treatment of cerebral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the prevention and treatment of cerebral... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3601872